Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapy.
about
Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreasTherapy for metastatic pancreatic neuroendocrine tumors.Measured human dosimetry of 68Ga-DOTATATE.[111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical studyPharmacotherapy of Zollinger-Ellison syndrome.Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancerTherapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesPancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.Evolving treatment strategies for management of carcinoid tumors.Targeting the somatostatin receptor in pituitary and neuroendocrine tumors.Zollinger-Ellison syndrome: recent advances and controversies.Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors.Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer TreatmentSynthesis of the first radiolabeled 188Re N-heterocyclic carbene complex and initial studies on its potential use in radiopharmaceutical applications.
P2860
Q26752757-A4D798AF-0058-4E1D-9D8B-7EC44ADC7D2DQ34357869-7B2AB760-35D1-4FC7-8C50-AF010EC0CD84Q35756123-ED5E645E-FCB4-4229-ACDB-A0BDF2BEDFBEQ36125639-8DE27A69-2C38-43E9-A9F5-3E606EFD8B85Q36632665-A6429324-E5CD-4853-87B7-94A83DCAC782Q36834005-9B5A33CE-8281-4C63-902B-5D1B3C79D1F2Q37125550-14AD923D-E351-4889-8710-4ACAFED58C47Q37631597-E32DE079-060E-45FE-A800-7BD1FC4DCEFEQ38124702-6E7B2FE5-F3E2-4AD9-B5FA-43A1E2220587Q38132768-1CAEEF4B-E784-4438-B4CF-FFCE548F742DQ38150165-23E9C562-E67B-4B14-A020-4C26AB3FE0E9Q38776596-21940CE6-1D87-4490-A643-C8BF738076A9Q40773502-1B2DBB02-EDBE-4A6B-A213-AF39D6ACE17EQ41244010-905727AA-6E92-46A4-ADBC-97C66AAE8F84Q41475179-D44F84A1-DF93-4FF5-B420-2B5208BF4D7FQ42110738-A67E05E9-56D6-4E40-B5DB-E3584B231642
P2860
Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment of gastroenteropancr ...... receptor radionuclide therapy.
@en
Treatment of gastroenteropancr ...... receptor radionuclide therapy.
@nl
type
label
Treatment of gastroenteropancr ...... receptor radionuclide therapy.
@en
Treatment of gastroenteropancr ...... receptor radionuclide therapy.
@nl
prefLabel
Treatment of gastroenteropancr ...... receptor radionuclide therapy.
@en
Treatment of gastroenteropancr ...... receptor radionuclide therapy.
@nl
P2093
P2860
P356
P1433
P1476
Treatment of gastroenteropancr ...... receptor radionuclide therapy.
@en
P2093
Boen L R Kam
Dik J Kwekkeboom
Eric P Krenning
Esther I van Vliet
Jaap J M Teunissen
Marion de Jong
P2860
P356
10.1159/000335018
P577
2012-01-10T00:00:00Z